Editas Pursuing CRISPR: A Speculative Gem – Seeking Alpha
Seeking Alpha |
Editas Pursuing CRISPR: A Speculative Gem
Seeking Alpha Editas is a leading member of the cabal of biotech stocks pursuing the CRISPR Holy Grail. Editas is a licensee of the Broad Group and is in a bare knuckles patent brawl with the UCB crowd and others. Editas offers heaping helpings of long term … |
